Research Article
Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer
Table 3
Univariate and multivariate analysis of RFS in patients with cervical cancer.
| Parameters | Univariate analysis | Multivariate analysis | | HR | 95% CI (lower/upper) | | HR | 95% CI (lower/upper) |
| Age | 0.733 | 1.005 | 0.978 | 1.033 | | | | | Histology | | | | | | | | | Squamous cell carcinoma | | 1.000 | | | | | | | Adenocarcinoma | 0.426 | 1.441 | 0.586 | 3.545 | | | | | Adenosquamous carcinoma | 0.222 | 3.535 | 0.466 | 26.821 | | | | | Clinical stage | | | | | | | | | III/IV vs. I/II | 0.974 | 1.015 | 0.415 | 2.486 | | | | | Lymphovascular invasion indicator | | | | | | | | | Absent vs. present | 0.006 | 0.128 | 0.029 | 0.562 | 0.007 | 0.131 | 0.030 | 0.572 | Radiation therapy | | | | | | | | | No vs. yes | 0.399 | 0.679 | 0.276 | 1.670 | | | | | Targeted molecular therapy | | | | | | | | | No vs. yes | 0.820 | 1.098 | 0.489 | 2.467 | | | | | Postoperative drugs | | | | | | | | | No vs. yes | 0.499 | 0.694 | 0.241 | 2.000 | | | | | miR-361-3p expression | | | | | | | | | High vs. low | 0.025 | 0.578 | 0.358 | 0.932 | 0.013 | 0.398 | 0.192 | 0.825 |
|
|